-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse NYSE New York Stock ExchangeISIN GB0009252882-
GlaxosmithklineBörse London Stock ExchangeISIN GB0009252882Symbol GSK
-
GlaxosmithklineBörse Börse FrankfurtISIN GB0009252882 WKN: 940561EURSymbol GS7
-
GlaxosmithklineBörse Börse BerlinEURSymbol GS7A
-
GLAXOSMITHKLINE PLC-SPON ADRBörse Börse FrankfurtEURSymbol GS7A
-
GlaxosmithklineBörse Börse StuttgartEURSymbol GS7A
-
GlaxosmithklineBörse Börse MünchenEURSymbol GS7A
-
GlaxosmithklineBörse Gettex System der Börse MünchenEURSymbol GS7A
-
GLAXOSMITHKLINE PLCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse BerlinEURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Quotrix System der Börse DüsseldorfEURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse HamburgEURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse DüsseldorfEURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse MünchenEURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Börse StuttgartEURSymbol GS7
-
GLAXOSMITHKLINE PLCBörse Gettex System der Börse MünchenEURSymbol GS7
-
GlaxosmithklineBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol GS7A
-
GlaxosmithklineBörse Börse HamburgEURSymbol GS7A
-
GlaxosmithklineBörse Quotrix System der Börse DüsseldorfEURSymbol GS7A
-
GlaxosmithklineBörse Börse DüsseldorfEURSymbol GS7A
-
GlaxosmithklineBörse NYSE New York Stock ExchangeISIN GB0009252882 WKN: 940561Symbol GSK
-
GlaxosmithklineBörse Amerikanscher Freiverkehr OTC oder "Pink Sheets"USDSymbol GSK.LN
-
GlaxoSmithKline PLC ADRBörse NYSE New York Stock ExchangeISIN US37733W1053 WKN: 940610Symbol GSK
-
INRGLAXOSMITHKLINE PHARMACEUTICALBörse BSE
-
USDGlaxosmithklineBörse Freiverkehr OTC
-
Symbol GS7
-
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
93.879.525.376 oder 82.199.000.000 oder 81.582.338.640
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
94.066 oder 90.096 Mitarbeiter
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
13.04 oder 18.9
Glaxosmithkline underperformed den DAX um -73 % vom 14.05.2014 bis 02.09.2022
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 1478,4 GBp +0,73%
Aktionärsstruktur der GlaxoSmithKline plc
Portrait der Glaxosmithkline Aktie
Das Unternehmen GlaxoSmithKline plc aus Großbritannien beschäftigt 92.081 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie & Pharmazeutika, Pharma tätig.
Die Glaxosmithkline Aktie konnte seit dem 14.05.2014 leider keine Rendite erwirtschaften. Die Kursverluste lagen bei -43%.
Das Unternehmen GlaxoSmithKline plc ist in mehr als 78 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares STOXX Europe Select Dividend 30 UCITS ETF (DE) gewichtet Glaxosmithkline mit 6,17% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Glaxosmithkline Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen GlaxoSmithKline plc am höchsten gewichtet ist Insgesamt in 78 ETFs enthalten
Dir gefallen die Informationen zu Glaxosmithkline?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
Dir gefallen die Informationen zu Glaxosmithkline?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Glaxosmithkline?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Glaxosmithkline?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
313 News & Informationen zur Glaxosmithkline Aktie
Astra’s Antibody Drug Prevents Covid-19 in High-Risk Groups
(Bloomberg) — AstraZeneca Plc’s Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to vulnerable groups.
Global Atopic Dermatitis Drugs Market Report 2021: Rising Incident of Food Allergies Intensifying Atopic Dermatitis – Forecast to 2026
DUBLIN, Aug. 19, 2021 /PRNewswire/ — The 'Global Atopic Dermatitis Drugs Market (2021-2026) by Drug Class, Route of Administration, Geography, Co…
Top Analyst Reports for Chevron, T-Mobile & American Express
Today's Research Daily features new research reports on 16 major stocks, including Chevron Corporation (CVX), T-Mobile US, Inc. (TMUS), and American Express Company (AXP).
Global Intranasal Drug Delivery Market Forecast to 2027: Burgeoning Geriatric Populace Spurs Growing Demand
/PRNewswire/ — The
Global Intranasal Drug Delivery Market Forecast To 2027: Burgeoning Geriatric Populace Spurs Growing Demand
DUBLIN, Aug. 19, 2021 /PRNewswire/ — The
Smoking Cessation Aids Market to exceed US$ 64,032.30 million by 2028 – COVID-19 Impact and Global Analysis by The Insight Partners
/PRNewswire/ — According to our new research study on “Smoking Cessation Aids Market Forecast to 2028 – by Product, End User, and Geography,” the Smoking…
Global Haemophilus influenzae Type B Infections 2021 Pipeline Guide and Drugs In Development
/PRNewswire/ — The “Haemophilus influenzae Type B Infections (Infectious Disease) – Drugs In Development, 2021” report has been added to…
Finding Global Leaders Outside of Tech
CI Black Creek Global Leaders’ Heather Pierce avoids big tech, but seeks opportunities elsewhere.
Eversept Partners, LLC Buys Bristol-Myers Squibb Company, Community Health Systems Inc, Organon, Sells , TG Therapeutics Inc, GlaxoSmithKline PLC
GuruFocus Article or News written by insider and the topic is about:
Perpetual Investment Management Limited Buys Merck Inc, JB Hunt Transport Services Inc, Vertiv Holdings Co, Sells Amerco Inc, Phillips 66, SeaWorld Entertainment Inc
GuruFocus Article or News written by insider and the topic is about:
Should You Sell Your GlaxoSmithKline (GSK) Position Before its Too Late?
Nelson Capital Management, an investment management firm, published its second-quarter 2021 investor letter – a copy of which can be downloaded here.
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET on Wednesday, 77 companies hit new 52-week highs.
Areas of Significance: Pfizer (NYSE:PFE) was the largest firm on a market …
Pulmonary Arterial Hypertension Market Size Worth $7.7 Billion By 2028: Grand View Research, Inc.
/PRNewswire/ — The global pulmonary arterial hypertension market size is expected to reach USD 7.7 billion by 2028, according to a new report by Grand View…
Pulmonary Arterial Hypertension Market Size Worth $7.7 Billion By 2028: Grand View Research, Inc.
SAN FRANCISCO, Aug. 18, 2021 /PRNewswire/ — The global pulmonary arterial hypertension market size is expected to reach USD 7.7 billion by 2028, …
Biologics Global Market Report 2021: COVID-19 Impact and Recovery to 2030
/PRNewswire/ — The
Biologics Global Market Report 2021: COVID-19 Impact And Recovery To 2030
DUBLIN, Aug. 17, 2021 /PRNewswire/ — The “Biologics Global Market Report 2021: COVID-19 Impact and Recovery to 2030” report has been added to
The Worldwide Smoking Cessation Aids Industry is Expected to Reach $64 Billion in 2028
/PRNewswire/ — The “Smoking Cessation Aids Market Forecast to 2028 – COVID-19 Impact and Global Analysis by\ Product (Nicotine Replacement Therapy, Drugs,…
The Worldwide Smoking Cessation Aids Industry is Expected to Reach $64 Billion in 2028
/PRNewswire/ — The “Smoking Cessation Aids Market Forecast to 2028 – COVID-19 Impact and Global Analysis by\ Product (Nicotine Replacement Therapy, Drugs,…
The Worldwide Smoking Cessation Aids Industry is Expected to Reach $64 Billion in 2028
/PRNewswire/ — The “Smoking Cessation Aids Market Forecast to 2028 – COVID-19 Impact and Global Analysis by\ Product (Nicotine Replacement Therapy, Drugs,…
The Worldwide Smoking Cessation Aids Industry is Expected to Reach $64 Billion in 2028
/PRNewswire/ — The “Smoking Cessation Aids Market Forecast to 2028 – COVID-19 Impact and Global Analysis by\ Product (Nicotine Replacement Therapy, Drugs,…
Global Active Pharmaceutical Ingredients/API Market To Reach $274.8 Billion By 2026
SAN FRANCISCO, Aug. 17, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today
Global Active Pharmaceutical Ingredients/API Market to Reach $274.8 Billion by 2026
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET on Tuesday, 55 companies set new 52-week highs.
Points of Interest: Apple (NASDAQ:AAPL) was the largest company by market …
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc. (NYSE: BIO) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Gilead Sciences, Inc. (NASDAQ: GILD) GlaxoSmithKline plc (NYSE: GSK) Johnson & Johnson (NYSE: JNJ) Laboratory Corporation of America Holdings (NYSE: LH) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) NanoVibronix, Inc. (NASDAQ: NAOV) (announced intention to enter over-
OncXerna Therapeutics Appoints C. Evan Ballantyne as Chief Financial Officer
WALTHAM, Mass., Aug. 17, 2021 (GLOBE NEWSWIRE) — OncXerna Therapeutics, Inc. (“OncXerna”), a precision medicine company using an innovative…
4 High-Yield Dividend Stocks to Boost Your Dividend Income By StockNews
4 High-Yield Dividend Stocks to Boost Your Dividend Income
Black Creek Investment Management Inc. Buys Baidu Inc, The Hain Celestial Group Inc, Pricesmart Inc, Sells Oracle Corp, Bank Bradesco SA, Merck Inc
GuruFocus Article or News written by insider and the topic is about:
CureVac stock gains after upbeat preclinical data on COVID-19 vaccine candidate on primates
Shares of CureVac N.V. undefined gained 0.4% in morning trading Monday, but bucked the selloff in the biotechnology sector and the broader stock market,…
Capitolis Advisors LLC Buys , iShares MSCI ACWI Index Fund, Alibaba Group Holding, Sells Willis Towers Watson PLC, Verisk Analytics Inc, Alphabet Inc
GuruFocus Article or News written by insider and the topic is about:
Worldwide Anti-Snoring Treatment Industry to 2027 – Players Include Apnea Science, SomnoMed and ResMed Among Others
/PRNewswire/ — The “Anti-Snoring Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027” report has been added to…
Global Cancer Vaccines Research Report 2021-2026: Leading Players are Merck & Co., GlaxoSmithKline and Dendreon
/PRNewswire/ — The
Consumer genetics company 23andMe loss widens in first earnings report since going public
Consumer genetics company 23andMe undefined posted its first quarterly earnings as a public company on Friday, after it merged with Richard Branson's…
23andMe Reports FY2022 First Quarter Financial Results
First quarter revenue up 23% over prior yearStrong cash balance of $770 millionContinuing to advance therapeutics portfolio to drive future revenue growth SUNNYVALE, Calif., Aug. 13, 2021… | August 13, 2021
India Anti-Fungal Drugs Markets Report 2021: Historical Data 2017-2020, Base Year Of 2021, Estimates For 2022 & Forecasts 2023-2027
DUBLIN, Aug. 12, 2021 /PRNewswire/ — The “India Anti-Fungal Drugs Market, By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), By Indication,
Report 2021, Shingles Vaccine Market Size, Share, Growth, Trends, Competitive Analysis, Revenue, Forecast
Key Prominent Players Covered in the Shingles Vaccine Market Research Report Are Merck & Co. Inc., GlaxoSmithKline plc, SK Bioscience and other key market…
GlaxoSmithKline Stock Is Undervalued, Spin-Off To Unlock Value (NYSE:GSK)
GlaxoSmithKline stock is undervalued, and the spin-off looks like a good deal for shareholders. See why we remain bullish on GSK stock and rate it as a buy.
Marlboro man shopping for asthma drugs puts investors in a bind
The battle for control of Vectura Group has put shareholders and the board in a bind, forced to decide if the highest bidder for the UK health care company is also the best owner
Global $14.2 Billion Alopecia Markets to 2028
/PRNewswire/ — The “Alopecia Market Size, Share & Trends Analysis Report by Disease Type (Alopecia Areata, Cicatricial, Traction, androgenetic Alopecia), by…
Global Anaphylaxis Treatment Market Research Report 2021: Rise in Cases of Allergies Post Administration of COVID-19 Vaccines
/PRNewswire/ — The “Anaphylaxis Treatment Market Forecast to 2028 – COVID-19 Impact and Global Analysis by Medication Type, Route of Administration, Allergy…
Were Hedge Funds Right About Advanced Micro Devices, Inc. (AMD)?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a…